共 190 条
- [1] Baldwin K.(2010)Acute ischemic stroke update Pharmacotherapy 30 493-514
- [2] Orr S.(2007)Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups [published errata appear in Stroke. 2007 Jun; 38 (6): e38 and Stroke. 2007 Sep; 38 (9): e96] Stroke 38 1655-711
- [3] Briand M.(2008)Guidelines for management of ischaemic stroke and transient ischaemic attack 2008 Cerebrovasc Dis 25 457-507
- [4] Adams H.P.(2009)Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association [published erratum appears in Stroke. 2010 Sep; 41 (9): e562] Stroke 40 2945-8
- [5] del Zoppo G.(2009)Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic Trends Neurosci 32 48-55
- [6] Alberts M.J.(2004)Equivocal roles of tissue-type plasminogen activator in stroke-induced injury Trends Neurosci 27 155-60
- [7] del Zoppo G.J.(1982)Kinetics of the activation of plasminogen by human tissue plasminogen activator: role of fibrin J Biol Chem 257 2912-9
- [8] Saver J.L.(1987)Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy J Cell Biochem 33 77-86
- [9] Jauch E.C.(1987)On behalf of the TIMI investigators. Thrombolysis In Myocardial Infarction (TIMI): comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator J Am Coll Cardiol 10 479-90
- [10] Yepes M.(1987)A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarction J Am Coll Cardiol 9 1205-13